Literature DB >> 3082344

Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.

I N Findlay, K MacLeod, M Ford, G Gillen, A T Elliott, H J Dargie.   

Abstract

The antianginal effects of nifedipine 20 mg three times a day and atenolol 100 mg once a day singly and in combination were investigated in 16 patients with angina pectoris. The amount of work that could be done before angina and ST depression appeared was significantly increased by atenolol and the combination but not by nifedipine. At peak exercise the number of leads on a 16 point precordial electrocardiogram map that demonstrated greater than or equal to 1 mm ST segment depression was significantly reduced from a mean (SD) of 5.0 (0.4) on placebo to 3.7 (0.6), 2.8 (0.4), and 2.3 (0.7) on nifedipine, atenolol, and the combination respectively. Mean resting left ventricular ejection fraction, assessed by gated radionuclide ventriculography, did not change during any active treatment phase but increased significantly during exercise only on nifedipine and the combination. The nifedipine/atenolol combination was the most effective treatment, and the data suggest that nifedipine may be used to best advantage in combination with a beta blocker.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082344      PMCID: PMC1232159          DOI: 10.1136/hrt.55.3.240

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  25 in total

1.  Response of left ventricular volume to exercise in man assessed by radionuclide equilibrium angiography.

Authors:  R Slutsky; J Karliner; D Ricci; G Schuler; M Pfisterer; K Peterson; W Ashburn
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

2.  Effects of propranolol on left ventricular function in normal men.

Authors:  S Port; F R Cobb; R H Jones
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

3.  Nifedipine and beta-blocker drugs.

Authors:  C J Anastassiades
Journal:  Br Med J       Date:  1980-11-08

4.  The dependence of the cardiac effects of nifedipine on the responses of the peripheral vascular system.

Authors:  P B Kurnik; A J Tiefenbrunn; P A Ludbrook
Journal:  Circulation       Date:  1984-05       Impact factor: 29.690

5.  Precordial electrocardiographic mapping after exercise in the diagnosis of coronary artery disease.

Authors:  K Fox; A Selwyn; J Shillingford
Journal:  Am J Cardiol       Date:  1979-03       Impact factor: 2.778

6.  Adverse interaction between nifedipine and beta-blockade.

Authors:  L H Opie; D A White
Journal:  Br Med J       Date:  1980-11-29

Review 7.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Authors:  P D Henry
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

8.  Effects of nifedipine on resistance vessels, arteries and veins in man.

Authors:  B F Robinson; R J Dobbs; C R Kelsey
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

9.  Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomized, crossover study with radionuclide ventriculography.

Authors:  D L Johnston; V A Gebhardt; A Donald; W J Kostuk
Journal:  Circulation       Date:  1983-12       Impact factor: 29.690

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  16 in total

Review 1.  The combination of slow-release nifedipine and atenolol for stable angina.

Authors:  D G Waller; V F Challenor
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina.

Authors:  S Wieshammer; M Hetzel; U Barnikel; M Höher; H Seibold; M Kochs; V Hombach
Journal:  Klin Wochenschr       Date:  1991-09-16

Review 3.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 4.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

Review 5.  Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.

Authors:  V F Challenor; D G Waller; C F George
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

6.  The total ischemic burden European trial (TIBET): design, methodology, and management. The TIBET Study Group.

Authors: 
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

7.  A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.

Authors:  I N Findlay; K MacLeod; G Gillen; A T Elliott; T Aitchison; H J Dargie
Journal:  Br Heart J       Date:  1987-04

8.  Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina.

Authors:  H el-Tamimi; G J Davies
Journal:  Br Heart J       Date:  1992-09

Review 9.  Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.

Authors:  Sanjay Kumar; Roger J C Hall
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.

Authors:  M Sandberg; R A Foale
Journal:  Drugs       Date:  1988       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.